Investigators defined an IOP spike as >40 mm Hg or an increase ≥10 mm Hg after injection. The population was older (mean age ...

Regeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects separate ...

Eylea's sales slump and pipeline setbacks have dragged REGN down 22.8% YTD, underperforming its peers and the S&P 500.

Regeneron is having difficulties again with its manufacturing partner Novo Nordisk, reporting that it expects two FDA decisions due this month for its eye disease drug Eylea will be delayed, while ...

Regeneron Pharmaceuticals, Inc. (REGN) reported second-quarter 2025 adjusted earnings per share (EPS) of $12.89, which ...

Prefilled syringes are not only convenient for at-home use, they also offer safety and convenience features for hospital ...

The prefilled syringe presentation offers a convenient administration option to healthcare professionals.

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.

BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...